Introduction
XP Power Ltd (LSE:XPP) is a leading global designer and manufacturer of critical power control solutions, holding an established and technologically vital position within the FTSE 250 index. Headquartered in Singapore and listed on the London Stock Exchange, XP Power provides mission-critical AC-DC power supplies, high-voltage power converters, and RF power systems to blue-chip original equipment manufacturers (OEMs) across three core global sectors: Semiconductor Manufacturing Equipment, Healthcare (medical imaging, surgical tools, and diagnostics), and Industrial Technology. With customized design-in architectures and a normalizing semiconductor capital equipment cycle, XP Power represents an established electronic engineering recovery business.
Latest Company News
Recent corporate disclosures from XP Power have highlighted positive operational momentum, stabilizing book-to-bill ratios, and significant commercial progress under executive leadership. In its latest financial updates, the company reported solid sequential revenue recovery, propelled by rising inquiry levels and design-in wins for next-generation semiconductor fabrication tools and advanced medical robotic surgery equipment. Global semiconductor equipment manufacturers have resumed order placements as global fabrication plants prepare for 2nm and 3nm chip production runs.
On the corporate and operational front, XP Power successfully completed a share capital raise and banking facility refinancing, establishing substantial balance sheet liquidity and eliminating debt covenant concerns. The company's new state-of-the-art manufacturing facility in Malaysia continues to ramp up production smoothly, providing high-efficiency manufacturing capacity that complements established factories in Vietnam and China.
In technological development, XP Power has accelerated engineering deployment of its proprietary high-voltage radio frequency (RF) matching networks and DC power modules specifically tailored for next-generation 3nm and 2nm semiconductor fabrication nodes. By engineering ultra-clean, tightly regulated power delivery systems that withstand extreme plasma etching and chemical vapor deposition chambers, XP Power secures critical sole-supplier design-in positions with the world's leading semiconductor equipment OEMs.
Financial Performance
Financially, XP Power exhibits high operational leverage, expanding gross profit margins toward 45%, and improving free cash flow conversion. Critical power supplies represent low-cost, high-consequence components: an electrical power failure inside an extreme ultraviolet (EUV) semiconductor scanner or a hospital MRI machine causes catastrophic downtime, granting XP Power substantial pricing resilience. As factory production volumes recover, overhead absorption across Malaysian and Vietnamese manufacturing plants is driving rapid operating margin recovery.
The company maintains a solid balance sheet with net debt leverage tracking comfortably below 1.5 times EBITDA, supported by working capital normalization as inventory holdings are liquidated. The board has reaffirmed its commitment to restoring progressive ordinary dividend distributions as operational free cash flows normalize.
FTSE 250 & UK Market Context
Within the FTSE 250 technology cohort, critical power supply engineering occupies an irreplaceable market niche. Converting AC mains electricity into ultra-stable, low-noise DC or radio-frequency (RF) power requires specialized power electronics design, thermal management, and strict electromagnetic interference (EMI) shielding. Achieving medical safety certifications (IEC 60601) and semiconductor cleanroom approvals takes years, locking in XP Power's customized components for customers' entire seven-to-ten-year product manufacturing lifecycles.
XP Power is executing an operational turnaround: having rejected earlier private capital takeover interest, the company's recovery is closely tied to the pace of global semiconductor equipment capital expenditure.
Sector Developments
The global semiconductor capital equipment and healthcare technology sectors are supported by multi-decade secular megatrends. The worldwide boom in artificial intelligence, high-performance computing, and automotive silicon drives hundreds of billions of dollars in new semiconductor fabrication facility construction worldwide, requiring thousands of XP Power's precision RF power generators for plasma etching and atomic layer deposition.
Furthermore, XP Power's healthcare division has experienced a sustained recovery in customer ordering patterns, particularly across robotic surgery, computerized tomography (CT) scanners, and patient monitoring systems. Medical equipment manufacturers require rigorous ISO 13485-certified quality standards and extended seven-to-ten-year product lifecycle commitments, insulating XP Power's medical gross margins from short-term macroeconomic volatility.
Simultaneously, demographic aging across developed markets drives relentless demand for robotic surgical instruments, patient monitoring systems, and laboratory blood analyzers, where XP Power's medical-grade power supplies hold an established position.
What Investors Are Watching
From an operational and balance sheet perspective, management's decisive refinancing actions and disciplined net working capital reductions have significantly improved group liquidity. With customer destocking in industrial technology approaching its conclusion and fab equipment utilization rates ticking upwards across East Asia and North America, XP Power possesses substantial operational leverage to translate incremental revenue directly into expanding operating margins.
Market participants are focused on several vital upcoming operational catalysts for XP Power. Foremost is the scheduled third-quarter trading update, where analysts will examine order intake book-to-bill ratios across Semiconductor and Healthcare, gross margin progression, and capacity utilization at the new Malaysian manufacturing facility. Scrutiny will also focus on working capital cash generation and net debt reduction.
Additionally, investors will watch for updates regarding commercial design-in wins for next-generation 3nm semiconductor equipment platforms, alongside board commentary on the timeline for resuming ordinary dividend distributions.
Conclusion
XP Power Ltd (LSE:XPP) remains a constituent of the FTSE 250 index. Its mission-critical design-in product profile, long product lifecycles, state-of-the-art Malaysian manufacturing capacity, resolved balance sheet liquidity, and exposure to global semiconductor and healthcare megatrends together define its current positioning.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...